 It has allowed people who were otherwise not a candidate for radiofrequency ablation to have a chance at having their problem cured.This technology was developed at The Montreal Heart institute in the late 1990s.The therapy was successfully adopted in Europe in 2001, and in the US in 2004 following the "Frosty Trial".